Biotech Values

[DewDiligence]

>NOVC – If you think Doxapin from Somaxon is a doomed product because of generics, how about a low dose ambien for middle of the night dosing when you can split a generic?<

Agreed—hopeless product from a commercial standpoint. Reminds me of NTMD’s BiDil.


<font size=2><font color=red>“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”